Back to top
more

Universal Health Services (UHS)

(Delayed Data from NYSE)

$205.26 USD

205.26
632,500

+0.95 (0.46%)

Updated Nov 1, 2024 04:00 PM ET

After-Market: $205.49 +0.23 (0.11%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth F Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 11% (28 out of 250)

Industry: Medical - Hospital

Better trading starts here.

Zacks News

Reasons to Hold Patterson Companies (PDCO) in Your Portfolio Now

Investors remain optimistic about Patterson Companies (PDCO) on the back of its broad product line.

Stryker's (SYK) Pangea System to Enhance Plating Solutions

Stryker (SYK) announces the launch of its Pangea Plating System, which is likely to provide solutions for internal fixation and stabilization of bone fractures.

PacBio (PACB) Q2 Earnings Beat Estimates, Revenues Down Y/Y

PacBio's (PACB) Product revenues decline in the second quarter of 2024. However, Consumable and Service and other revenues increase year over year.

Vicarious Surgical (RBOT) Partners LSU Health New Orleans

Vicarious Surgical (RBOT) teams up with LSU Health New Orleans to advance its V1.0 surgical robot. It aims to file for FDA approval by 2026.

McKesson (MCK) Q1 Earnings Beat Estimates, Revenues Up Y/Y

McKesson's (MCK) first-quarter fiscal 2025 results showcase growth in the U.S. Pharmaceutical segment. However, Medical Surgical Solutions suffers due to lower COVID-related sales.

Smith & Nephew (SNN), HOPCo to Enhance Musculoskeletal Care

Smith & Nephew (SNN) announces a collaboration with HOPCo to focus on enhancing solutions for ASC customers, physicians, and patients through the latter's digital health and analytics platforms.

Nevro's (NVRO) Q2 Earnings Beat Estimates, Revenues Down Y/Y

Nevro's (NVRO) second-quarter earnings beat the Zacks Consensus Estimate while worldwide revenues decline year over over. The company incurs a loss at the operating level.

Inogen (INGN) Q2 Earnings Beat Estimates, Revenues Rise Y/Y

Inogen's (INGN) second-quarter 2024 results reflect significant improvement in the top and bottom lines, driven by strong international and domestic business-to-business sales.

Inspire Medical (INSP) Q2 Earnings Beat, Gross Margin Rises

Inspire Medical (INSP) reports strong second-quarter results, reflecting a 30% revenue increase. Its new technology and expanded U.S. presence promise growth and enhanced patient care.

Reasons to Retain PacBio (PACB) Stock in Your Portfolio Now

PacBio's (PACB) strong product demand and continued focus on R&D raise optimism about the stock.

Baxter (BAX) Q2 Earnings Beat Estimates, '24 EPS View Raised

Baxter (BAX) reports better-than-expected second-quarter earnings and sales. Its quarterly results reflect solid demand for a range of its medically essential products.

Stryker (SYK) Completes MOLLI's Acquisition to Boost Business

Stryker (SYK) completes of the acquisition of MOLLI, a privately held company, to strengthen its commitment to advancing surgical solutions in breast cancer care.

CooperCompanies (COO) Acquires obp Surgical to Boost Portfolio

CooperSurgical, a unit of CooperCompanies (COO), acquires obp Surgical for $100 million, adding innovative single-use surgical retractors and suction devices to its portfolio.

Zacks.com featured highlights include Universal Health Services, General Motors, Unum and PVH

Universal Health Services, General Motors, Unum and PVH have been highlighted in this Screen of The Week article.

Acadia Healthcare (ACHC) Shares Up 12% on Q2 Earnings Beat

Acadia Healthcare's (ACHC) Q2 results reflect higher revenue per patient day and increased patient days. It currently estimates 2024 adjusted EPS within $3.45-$3.65 compared with the earlier view of $3.40-$3.70.

Microbot Medical (MBOT) Inks Deal to Test Autonomous Robotics

Microbot Medical (MBOT) announces an agreement with Emory University to explore the potential of integrating robotics, procedure planning and navigation into a single autonomous system.

Inspire Medical (INSP) Gets FDA Nod for Inspire V System

Inspire Medical (INSP) secures FDA approval for its advanced Inspire V therapy system, featuring an innovative neurostimulator and Bluetooth technology for enhanced patient and physician control.

Sumit Singh headshot

4 Low P/CF Stocks to Turn Market Volatility Into Opportunity

Value investing is essentially about selecting stocks that are cheap but fundamentally sound. UHS, GM, UNM & PVH boast a low P/CF ratio.

Merit Medical (MMSI) Q2 Earnings & Revenues Beat, '24 View Up

Merit Medical's (MMSI) second-quarter results reflect growth in earnings and revenues. Operating margin expands.

Ecolab (ECL) Sells Surgical Solutions Business to Medline

Ecolab's (ECL) deal to sell its global surgical solutions business to Medline enables it to focus on infection prevention and instrument reprocessing while enhancing shareholders' returns.

Are Investors Undervaluing Universal Health Services (UHS) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks.com featured highlights Universal Health Services, Tenet Healthcare Corp., Century Communities and Magnite

Universal Health Services, Tenet Healthcare Corp., Century Communities and Magnite are part of the Zacks Screen of the Week article.

QuidelOrtho (QDEL) Q2 Earnings Beat Estimates, U.S. Sales Down

QuidelOrtho's (QDEL) second-quarter results reflect growth in revenues. However, gross profit continues to decline.

CONMED (CNMD) Q2 Earnings Beat, Sales Rise Y/Y, '24 View Cut

CONMED (CNMD) beats second-quarter earnings estimates on the back of higher revenues and lower costs and expenses. However, the result reflects the continued impact of supply chain issues.

Vasundhara Sawalka headshot

4 Stocks Trading Near 52-Week High That Can Climb Further

Investors target stocks that have been on a bullish run lately. Stocks like UHS, THC, CCS and MGNI that are seeing price strength have a high chance of carrying the momentum forward.